BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 8, 2011
View Archived Issues
Four-marker signature exhibits improved prognostic accuracy in prostate cancer progression
Read More
Azacitidine has dual mechanism of action in resistant cancer cells
Read More
PTC Therapeutics achieves first milestone in BMI-1 collaboration with Wellcome Trust
Read More
BioDelivery Sciences announces results of FDA meeting on BEMA-delivered buprenorphine/naloxone
Read More
Novel HCV NS3/NS4A inhibitors patented by Idenix
Read More
Novel IAP inhibitors for treatment of cancer designed at Takeda
Read More
Servier presents new anticancer dihydroindolone analogues
Read More
Infinity Pharma's IPI-926 enters phase II trial and receives FDA orphan status in chondrosarcoma
Read More
Noscira presents new inhibitors of beta-secretase 1 and Abeta production
Read More
Kissei claims new catechol O-methyltransferase inhibitors
Read More
French scientists present new CK II inhibitors
Read More
FDA clears Palatin Technologies' IND for phase IIa PL-3994 trial in asthma
Read More
Cempra Pharma provides pipeline update on solithromycin and Taksta
Read More
InterMune receives approval for Esbriet in Europe
Read More
Endo Pharma launches Fortesta testosterone gel in U.S.
Read More
Novel TGFR-2-based trap T22d35 reduces tumor growth in vivo
Read More
ACT Biotech files SPA with FDA for phase III telatinib trial
Read More
Lycera and Merck & Co. enter into autoimmune treatment collaboration
Read More
AGS-004 delays rebound of HIV during interruption of antiretroviral therapy
Read More
Phase III ORAL Sync trial of Pfizer's tofacitinib meets primary endpoints
Read More
FDA approves removal of boxed warning regarding liver injury from Letairis label
Read More
European Commission approves Firazyr self-administration label for HAE
Read More
Ziopharm grants exclusive license to Solasia for Zinapar in Asia
Read More
Vical and EMA reach agreement on endpoints for pivotal phase III trial of TransVax vaccine
Read More
MediciNova and Zhejiang Medicine form partnership for MN-221 in China
Read More